Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs MetaVia Inc. (MTVA)

Kiora Pharmaceuticals, Inc. and MetaVia Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and MetaVia Inc. are of similar size ($7.2M and $6.6M). Across the 10 metrics below, Kiora Pharmaceuticals, Inc. leads on 6 and MetaVia Inc. on 4.

Valuation

Metric KPRX MTVA Biotechnology median
P/E n/m n/m 10.60
P/S 0.47 n/m 9.40
P/B 0.52 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.62 0.04 0.66
EV/Sales (0.42) n/m 9.02
Earnings yield (174.20%) (285.73%) (32.88%)
Free cash flow yield (98.19%) (190.70%) (23.13%)

Profitability

Metric KPRX MTVA Biotechnology median
Gross margin 85.06% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (175.68%) (51.96%)
Return on assets (39.43%) (91.06%) (46.06%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX MTVA Biotechnology median
Revenue growth (TTM) 983.73% — 6.76%
EPS growth (last fiscal year) (403.45%) 81.23% 29.88%
Revenue growth, 5-year CAGR 88.72% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 2.06 4.97
Net debt to EBITDA 1.33 0.75 1.01

Dividend

Metric KPRX MTVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KPRX MTVA Biotechnology median
Market cap 6.63m 7.18m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack